Full Text View
Tabular View
No Study Results Posted
Related Studies
Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
This study has been completed.
Study NCT00247975   Information provided by University of Ottawa Heart Institute

First Received on October 31, 2005.   Last Updated on February 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Cardiovascular Diseases
Heart Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
L-carnitine
Additional drug interventions recognized in this trial
Carnitine
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamin B Complex
Vitamins
Sponsors listed in this trial
University of Ottawa Heart Institute
Canadian Institutes of Health Research (CIHR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services